Additionally, an obstacle to drug treatment for obesity is that the drug is perceived as ineffective because the patient gains weight again when the drug is stopped
9 Sn phm thay th GoodLife Aqua White l sn phm ca thng hiu Goodlife Pharma, c thnh phn Collagen, L-Glutathione, Nicotinamide, vitamin C, B6, L-Cystine, Acid hyaluronic, chit xut nho v to c cng dng h tr lm trng sng da, gip dng m, ngn nga lo ha da
Were there adequate controls
Theres a reason why medications have to go through a regulatory body like the FDA
NAION patients typically experience the following symptoms: Sudden, painless vision loss typically noticed upon waking Altitudinal visual field defects (loss of upper or lower half of vision) Decreased color vision (dyschromatopsia) and light sensitivity Reduced contrast sensitivity Relative afferent pupillary defect (Marcus Gunn pupil) Visual acuity ranging from mild blurring to complete blindness The unilateral nature of initial NAION presentation means most patients experience vision loss in one eye while maintaining normal vision in the other
Theres already a pathway for GLP-1 drugs to become some of the most prescribed medicines in the US